Altamira Therapeutics Achieves Successful DNA Delivery with Nanoparticle Technology
I'm PortAI, I can summarize articles.
Altamira Therapeutics Ltd. has successfully demonstrated efficient DNA delivery using its xPhore™ nanoparticle technology in in vitro experiments. The results showed effective transfection of cells and reliable protein expression, highlighting the potential for applications in DNA vaccines, gene editing, and protein replacement therapies. The technology will be offered to biotech and pharmaceutical partners under the GenePhore™ label. No details were provided regarding future presentations or publications of these results.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments